Astedt B, Tropé C
Experientia. 1980 Jun 15;36(6):679-80. doi: 10.1007/BF01970136.
The fibrinolytic inhibitor tranexamic acid affects certain experimental tumours; it prolongs survival (Lewis lung adenocarcinoma), decreases tumour weight (C3H breast carcinoma), and inhibits ascitic production (AH 130 rat hepatoma). However, it does not significantly influence DNA-synthesis in cell suspensions prepared from the same tumours.
纤维蛋白溶解抑制剂氨甲环酸对某些实验性肿瘤有影响;它可延长生存期(Lewis肺癌),减轻肿瘤重量(C3H乳腺癌),并抑制腹水生成(AH 130大鼠肝癌)。然而,它对从相同肿瘤制备的细胞悬液中的DNA合成没有显著影响。